ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,765 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichMedropharm AG
Medropharm AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

Medropharm AG is a full-service provider for medical cannabis, offering strain development, GMP-compliant processing, controlled-substance storage, contract manufacturing, regulatory services, and wholesale distribution.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

Medropharm AG

✓ Offered12
GMP processing of medical cannabis
GMP-compliant processing of cannabis flowers, safe, traceable and scalable; including processing for regulated healthcare markets and pharmaceutically precise manufacturing.
Contract manufacturing
Contract manufacturing for the food, cosmetics and feed industry; development and production of quality products with modern technology and safe manufacturing.
Private Label
Development, production and packaging of private-label products; implementation of product ideas from concept to market readiness with support during the development phase.
Product development and approval
Development of products from the idea and market analysis through to scale-up; including regulatory support and guidance up to marketability.
Regulatory Services
Regulatory support for products and projects; guidance through complex requirements, compliance and market access in regulated markets.
Wholesale and distribution
Wholesale and distribution for cannabis-based products and healthcare products; supporting the supply chain for regulated markets.
BtM storage
BtM storage for medical cannabis and other regulated products; part of the secure, end-to-end supply chain.
Research and development
Research on genetics, raw materials, formulations and feasibility studies; support from the idea to the market-ready product.
Extraction and production
Extraction and production with short-path distillation and extraction systems at laboratory, pilot and production scale.
Products for animal health
Plant-based animal health products; developed and produced for balanced, healthy nutrition of animals.
Cosmetics
Development, approval and contract manufacturing for cosmetic products; including primary packaging materials and guidance from idea to market readiness.
Dietary supplements
Development and contract manufacturing of dietary supplements; tailored solutions with consulting and process know-how.
Trust & reputation

ranQ Trust Score of Medropharm AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 100% · As of October 2026

Medropharm AG scores 56.6 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.70.824%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.27.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.50.08%
Medropharm AG scores 83.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Medropharm AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Medropharm AG scores 66.5 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.82.94%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.50.04%
Qualifications+0.00

Medropharm AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». The rating draws, among other things, on 5.0 out of 5 stars from 2 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 2 reviews across all connected sources

Sources
GGoogle52
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

December 1, 2025Media
Pacrim acquires Swiss cannabis pioneer Medropharm
startupticker.ch
February 20, 2025Media
Marokko: Medropharm AG startet legalen Haschisch-Export
20min.ch
February 19, 2025Media
Premiere: Thurgauer Medropharm handelt mit medizinischem Haschisch aus Marokko
tagblatt.ch
August 21, 2017Media
KRADOLF: Medropharm-Gründer übergeben Firmenleitung
tagblatt.ch
July 15, 2015Media
Dem Cannabis verfallen
luzernerzeitung.ch

Knowledge

No knowledge articles yet

Once Medropharm AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Medropharm AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Medropharm AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Medropharm AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Binzstrasse 23
8045 Zurich
Opening hours
Mon
08:00 - 17:00
Tue
08:00 - 17:00
Wed
08:00 - 17:00
Thu
08:00 - 17:00
Fri
08:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-392.732.383
Founded
2014 · 12 years
Last commercial register change
February 23, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.85.03%
    • Full methodology

    Similar companies

    AP
    Aurora Pharma AG
    Affoltern Am Albis
    ST
    swisscann tec AG
    Zurich
    AP
    Abela Pharm GmbH
    Zurich
    CG
    CONARTIX GmbH
    Schlieren
    HA
    Herb-pharma AG
    Zurich
    PG
    PharConSwiss GmbH
    Winkel
    WG
    Widalia GmbH
    Zurich
    TP
    Trias Pharma GmbH
    Winterthur